{"id":"hemoblast-bellows-application","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection at application site"},{"rate":null,"effect":"Hematoma formation"},{"rate":null,"effect":"Allergic reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The product consists of a collagen-based matrix impregnated with thrombin that promotes clot formation when applied directly to bleeding tissue. The bellows applicator delivers the hemostatic agent with controlled pressure to ensure optimal contact and absorption at the wound site, facilitating rapid platelet aggregation and fibrin deposition.","oneSentence":"Hemoblast Bellows is a hemostatic agent that combines a thrombin-based collagen sponge with a bellows applicator to achieve rapid hemostasis at surgical bleeding sites.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:39:52.985Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemostasis during surgical procedures where bleeding control is needed"}]},"trialDetails":[{"nctId":"NCT06511778","phase":"PHASE4","title":"sTErnAl heMostasiS Trial","status":"RECRUITING","sponsor":"WakeMed Health and Hospitals","startDate":"2024-10-17","conditions":"Excessive Bleeding During Surgery","enrollment":60},{"nctId":"NCT03725098","phase":"NA","title":"Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations","status":"COMPLETED","sponsor":"Biom'Up France SAS","startDate":"2019-03-01","conditions":"Cardiothoracic Surgery","enrollment":105}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Hemoblast Bellows application","genericName":"Hemoblast Bellows application","companyName":"WakeMed Health and Hospitals","companyId":"wakemed-health-and-hospitals","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hemoblast Bellows is a hemostatic agent that combines a thrombin-based collagen sponge with a bellows applicator to achieve rapid hemostasis at surgical bleeding sites. Used for Hemostasis during surgical procedures where bleeding control is needed.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}